Dr. Adams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1150 NW 14th St
Miami, FL 33136Phone+1 305-243-3100Fax+1 305-243-4678
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1970 - 1974
University of Washington School of MedicineInternship, Transitional Year, 1969 - 1970
Columbia University Vagelos College of Physicians and SurgeonsClass of 1969
Certifications & Licensure
FL State Medical License 2008 - 2024
NY State Medical License 1970 - 2009
NJ State Medical License 1978 - 2007
GA State Medical License 1992 - 1995
NC State Medical License 1972 - 1982- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1 citationsSaturation genome editing of BAP1 functionally classifies somatic and germline variants.Andrew J Waters, Timothy Brendler-Spaeth, Danielle Smith, Victoria Offord, Hong Kee Tan
Nature Genetics. 2024-07-01 - 4 citationsCross-species oncogenomics offers insight into human muscle-invasive bladder cancer.Kim Wong, Federico Abascal, Latasha Ludwig, Heike Aupperle-Lellbach, Julia Grassinger
Genome Biology. 2023-08-28 - 7 citationsNicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins.Han-Shen Tae, David J Adams
Pharmacological Research. 2023-05-01
Press Mentions
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy: French Experience About Four Patients, Under the Behalf of French Society for Bone Marrow TransplantationMarch 2nd, 2021
Oligonucleotide Drugs Show Promise in Transthyretin AmyloidosisJuly 5th, 2018
Alnylam RNAi Drug Reverses Progress of Rare Fatal Disease: StudyNovember 2nd, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
